Press Releases 4basebio PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:21 2024-06-06 am EDT			5-day change	1st Jan Change
1,520 ^GBX	+6.67%		+8.19%	+123.53%

Jun. 05	4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 10	4basebio to supply synthetic DNA for mRNA vaccine program	AN

4basebio : Results Announcement 2023	Jun. 05	PU
4basebio : Form of Proxy 2024	Jun. 05	PU
4basebio : Notice of AGM 2024	Jun. 05	PU
4basebio Plc - Final Results and Notice of AGM	Jun. 05	PR
4basebio Plc - Holding(s) in Company	May. 30	PR
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	Apr. 10	PR
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	Mar. 21	PR
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	Mar. 01	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 06	PR
4basebio Plc - Exercise of Options	Feb. 06	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Holding(s) in Company	Feb. 05	PR
4basebio Plc - Directors' Dealings	Feb. 05	PR
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	Feb. 02	PR
4basebio Plc - Half-year Report	23-09-21	PR
4basebio : receives grant to advance its synthetic DNA platform and HermesTM nanoparticle platform for the development of thermostable nucleic acid vaccines	23-08-01	PU

No results for this search